Uli Bialucha
Chief Tech/Sci/R&D Officer bei XILIO THERAPEUTICS, INC.
Profil
Uli Bialucha is currently the Chief Scientific Officer at Xilio Therapeutics, Inc. Previously, Uli held the position of Vice President-Drug Discovery at Immunitas Therapeutics, Inc. Uli completed their undergraduate degree at the University of Sussex and obtained a doctorate from University College London.
Aktive Positionen von Uli Bialucha
| Unternehmen | Position | Beginn |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.04.2021 |
Ehemalige bekannte Positionen von Uli Bialucha
| Unternehmen | Position | Ende |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Uli Bialucha
| University of Sussex | Undergraduate Degree |
| University College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Health Technology |
